Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 18;15(12):1581.
doi: 10.3390/ph15121581.

Challenges in the Pharmacotherapeutic Management of Pediatric Asthma

Affiliations
Review

Challenges in the Pharmacotherapeutic Management of Pediatric Asthma

Ileana Ioniuc et al. Pharmaceuticals (Basel). .

Abstract

Bronchial asthma is one of the most common chronic conditions in pediatric practice, with increasing prevalence hampered by poor socioeconomic impacts, leading to major public health issues. Considered as a complex heterogeneous syndrome, not a single disease, the management of the disease is a real challenge, impacting medical staff, patients and caregivers. Over the decades, a significant number of diagnostic and treatment regimen have been developed to achieve good standards, sustaining balanced control of the disease. This paper attempts a review on the establishment of new trends in the management of bronchial asthma in the pediatric age group.

Keywords: GINA; adolescent; child; pediatric bronchial asthma; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Asthma treatment based on GINA 2022 recommendations for children aged 6–11 [6] and adapted from Recent Advances in Long-Term Management of Asthma (published online ahead of print, 20 January 2022). Indian J Pediatr. 2022 [42].
Figure 2
Figure 2
Asthma treatment based on GINA 2022 recommendations for children aged ≥12 and adapted from Recent Advances in Long-Term Management of Asthma (published online ahead of print, 20 January 2022). Indian J Pediatr. 2022 [42].
Figure 3
Figure 3
Management of severe forms of asthma adapted to GINA 2022 recommendations and from Recent Advances in Long-Term Management of Asthma (published online ahead of print, 20 January 2022). Indian J Pediatr. 2022 [42].
Figure 4
Figure 4
Therapeutic management of acute exacerbations adapted from the Spanish asthma management guide GEMA 5.0 [3] and GINA 2022 [6].

Similar articles

Cited by

References

    1. Gaillard E.A., Kuehni C.E., Turner S., Goutaki M., Holden K.A., de Jong C.C., Lex C., Lo D.K., Lucas J.S., Midulla F., et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years. Eur. Respir. J. 2021;58:2004173. doi: 10.1183/13993003.04173-2020. - DOI - PubMed
    1. Papadopoulos N.G., Čustović A., Cabana M.D., Dell S.D., Deschildre A., Hedlin G., Hossny E., Le Souëf P., Matricardi P.M., Nieto A., et al. Pediatric asthma: An unmet need for more effective, focused treatments. Pediatr. Allergy Immunol. 2019;30:7–16. doi: 10.1111/pai.12990. - DOI - PMC - PubMed
    1. Pellegrini Belinchon J., Ortega Casanueva C., Ariiba Mendez S. New approach in the treatment pf children with asthma. Pediatr. Integral. 2021;XXV:67–75–EN.
    1. Dharmage S.C., Perret J.L., Custovic A. Epidemiology of Asthma in Children and Adults. Front. Pediatr. 2019;7:246. doi: 10.3389/fped.2019.00246. - DOI - PMC - PubMed
    1. Kalayci O., Abdelateef H., Pozo Beltrán C.F., El-Sayed Z.A., Gómez R.M., Hossny E., Morais-Almeida M., Nieto A., Phipatanakul W., Pitrez P., et al. Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician. World Allergy Organ. J. 2019;12:100054. doi: 10.1016/j.waojou.2019.100054. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources